192 related articles for article (PubMed ID: 6411432)
1. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
3. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of primary therapy for DIC following circulatory arrest.
Takemoto Y; Tanaka S; Tanabe J; Nakamura Y; Kohama A; Shibata S
Am J Hematol; 1986 Apr; 21(4):377-82. PubMed ID: 3082185
[TBL] [Abstract][Full Text] [Related]
6. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
[No Abstract] [Full Text] [Related]
8. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Wakui K; Takemae T; Kobayashi S
No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation.
Kumon K; Tanaka K; Nakajima N; Naito Y; Fujita T
Crit Care Med; 1984 Dec; 12(12):1039-43. PubMed ID: 6439471
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
Isobe J
Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
[TBL] [Abstract][Full Text] [Related]
12. New approach to regional anticoagulation in hemodialysis using gabexate mesilate (FOY).
Taenaka N; Shimada Y; Hirata T; Nishijima M; Yoshiya I
Crit Care Med; 1982 Nov; 10(11):773-5. PubMed ID: 6814824
[TBL] [Abstract][Full Text] [Related]
13. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
14. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
[TBL] [Abstract][Full Text] [Related]
16. [Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
Taniguchi N; Kitani T; Kawagoe H; Horiuchi A; Masaoka T; Yasunaga K; Okamoto Y; Ohkubo A; Yonezawa T; Nagai K
Rinsho Ketsueki; 1987 Oct; 28(10):1729-37. PubMed ID: 3133506
[No Abstract] [Full Text] [Related]
17. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
[No Abstract] [Full Text] [Related]
18. Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial.
Okamura T; Niho Y; Itoga T; Chiba S; Miyake M; Kotsuru M; Saito H; Ichimaru M; Hara K; Takatsuki K
Acta Haematol; 1993; 90(3):120-4. PubMed ID: 8291369
[TBL] [Abstract][Full Text] [Related]
19. Survival from DIC following amniotic fluid embolism. Successful treatment with a serine proteinase inhibitor; FOY.
Taenaka N; Shimada Y; Kawai M; Yoshiya I; Kosaki G
Anaesthesia; 1981 Apr; 36(4):389-93. PubMed ID: 6787945
[TBL] [Abstract][Full Text] [Related]
20. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
